BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22827427)

  • 1. Electronic records suggest suboptimal management of chronic kidney disease in general practice.
    Pilotto LS; Ball PA; Smithard JM; Kennedy DR
    Aust J Rural Health; 2012 Aug; 20(4):195-9. PubMed ID: 22827427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic kidney disease and its risk factors among family practice patients in Lithuania.
    Bumblyte IA; Zilinskiene A; Vanholder R; Valius L; Kuzminskis V
    Clin Nephrol; 2012 Sep; 78(3):198-206. PubMed ID: 22874108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention.
    Zachariah D; Brown R; Kanagala P; Bashir A; Mohan M; Callan P; Rajendra R; Clark AL; Squire I; Gunning M; Lang CC; Kalra PR
    QJM; 2014 Mar; 107(3):185-92. PubMed ID: 24194563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT; Huang YB; Lin MY; Chuang PF; Hwang SJ
    Kaohsiung J Med Sci; 2012 Sep; 28(9):477-83. PubMed ID: 22974666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.
    Qiao Y; Shin JI; Sang Y; Inker LA; Secora A; Luo S; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
    Mayo Clin Proc; 2019 Nov; 94(11):2220-2229. PubMed ID: 31619367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to available clinical practice guidelines for initiation of antihypertensive medication in patients with or without diabetes mellitus and other comorbidities in Taiwan.
    Chou CC; Lin WS; Kao TW; Chang YW; Chen WL
    J Clin Pharmacol; 2012 Apr; 52(4):576-85. PubMed ID: 22021568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The care for chronic heart failure by general practitioners. Results from a clinical audit in Italy.
    Cancian M; Battaggia A; Celebrano M; Del Zotti F; Novelletto BF; Michieli R; Saugo M; Pellizzari M; Toffanin R
    Eur J Gen Pract; 2013 Mar; 19(1):3-10. PubMed ID: 22998169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
    Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19.
    Tetlow S; Segiet-Swiecicka A; O'Sullivan R; O'Halloran S; Kalb K; Brathwaite-Shirley C; Alger L; Ankuli A; Baig MS; Catmur F; Chan T; Dudley D; Fisher J; Iqbal MU; Puczynska J; Wilkins R; Bygate R; Roberts P
    J Intern Med; 2021 May; 289(5):688-699. PubMed ID: 33210357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported prescribing for hypertension in general practice.
    O'Riordan S; Mackson J; Weekes L
    J Clin Pharm Ther; 2008 Oct; 33(5):483-8. PubMed ID: 18834362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug dosing in patients with renal insufficiency in a hospital setting using electronic prescribing and automated reporting of estimated glomerular filtration rate.
    Nielsen AL; Henriksen DP; Marinakis C; Hellebek A; Birn H; Nybo M; Søndergaard J; Nymark A; Pedersen C
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):407-13. PubMed ID: 24373255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States.
    Murphy DP; Drawz PE; Foley RN
    J Am Soc Nephrol; 2019 Jul; 30(7):1314-1321. PubMed ID: 31167823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension management in outpatient visits by diabetic patients.
    Aparasu RR; Aparasu A
    Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study.
    Wolak T; Aliev E; Rogachev B; Baumfeld Y; Cafri C; Abu-Shakra M; Novack V
    Isr Med Assoc J; 2013 Nov; 15(11):682-7. PubMed ID: 24511648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice.
    Barrios V; Coca A; Escobar C; Enrique R; Rincón LM
    Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):159-66. PubMed ID: 22292872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.
    Samal L; Wright A; Waikar SS; Linder JA
    BMC Nephrol; 2015 Oct; 16():162. PubMed ID: 26458541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
    Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
    Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020.
    Nicholas SB; Daratha KB; Alicic RZ; Jones CR; Kornowske LM; Neumiller JJ; Fatoba ST; Kong SX; Singh R; Norris KC; Tuttle KR
    Diabetes Obes Metab; 2023 Oct; 25(10):2970-2979. PubMed ID: 37395334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.